• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » ResMed opens manufacturing plant in Singapore

ResMed opens manufacturing plant in Singapore

November 17, 2022 By Danielle Kirsh

Google map showing location of Singapore where ResMed has a new manufacturing facility
[Image courtesy of Google]
ResMed (NYSE: RMD, ASX: RMD) this week announced the grand opening of its new Advanced Manufacturing Center in Singapore’s Tuas area.

The new 270,000-square-foot facility doubles the respiratory care company’s presence in Singapore to serve its key manufacturing hub in Asia Pacific. The facility will employ nearly 1,000 people and has smart dashboards that integrate real-time data to monitor the performance of production lines.

ResMed’s new facility also has the manufacturing capacity and footprint to scale production for connected devices and mask systems. The company plans to use the new facility to produce its latest positive airway pressure (PAP) system, which allows users to monitor their own sleep apnea treatment.

“Singapore’s strategic location and support for business investment, coupled with ResMed’s world-leading devices and digital health offerings, provides the perfect opportunity to expand our manufacturing capabilities while supporting local jobs and the region’s economy,” CEO Mick Farrell said in a news release. “The opening of this facility supports the continued growth of ResMed’s product portfolio to meet the needs of millions of people across Singapore, Asia-Pacific, and the world.”

The newest Singapore-based manufacturing center is just one of a few new medtech facilities opening in the region. Earlier this month, Smith+Nephew opened a major medical education and digital innovation center to cover the Asia-Pacific region. Olympus’ Evident also opened its Asia-Pacific headquarters in Singapore in October.

“This facility marks a major milestone for ResMed, both in your growth as a world-leading medical device company, and in the expansion of your footprint in Singapore. I am glad ResMed has chosen Singapore as your partner in innovation and growth,” said Senior Minister Tharman Shanmugaratnam.

Filed Under: Business/Financial News, Featured, News Well, Respiratory Tagged With: ResMed, Singapore

More recent news

  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure
  • Ambu wins FDA clearance for first single-use cysto-nephroscope

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy